Antrim, United Kingdom

Catherine Mulholland

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Luxembourg Institute of Science and Technology. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Mulholland. Retrieved from https://idiyas.com/inventor/catherine-mulholland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Catherine Mulholland

Introduction

Catherine Mulholland is a notable inventor based in Antrim, Ireland. She has made significant contributions to the field of biotechnology, particularly in the development of DNA aptamers. Her work focuses on creating specific binding agents for adenoviruses, which are crucial for various medical applications.

Latest Patents

Catherine holds a patent for "DNA aptamers specific of adenovirus types." This invention involves a single-stranded nucleic acid aptamer that can specifically bind to at least one adenovirus type. The aptamer comprises or consists of one of the sequences SEQ ID NO:1 to 3, or variants thereof having at least 50% sequence identity. Additionally, her patent includes a composition comprising the aptamer, as well as methods for detecting, capturing, concentrating, and quantifying adenovirus types. Furthermore, it outlines a kit designed for these purposes.

Career Highlights

Catherine is affiliated with the Luxembourg Institute of Science and Technology, where she continues her research and development efforts. Her work has garnered attention for its potential applications in diagnostics and therapeutics.

Collaborations

Catherine collaborates with esteemed colleagues, including Leslie Ogorzaly and Samuel Jourdan, who contribute to her research endeavors.

Conclusion

Catherine Mulholland's innovative work in the field of DNA aptamers represents a significant advancement in biotechnology. Her contributions have the potential to enhance the detection and treatment of adenovirus infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…